Koninklijke Philips Net Profit Margin 2010-2025 | PHG
Current and historical net profit margin for Koninklijke Philips (PHG) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Koninklijke Philips net profit margin for the three months ending March 31, 2025 was .
| Koninklijke Philips Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $18.81B | $0.84B | 4.49% |
| 2024-09-30 | $18.97B | $0.05B | 0.26% |
| 2024-06-30 | $18.60B | $-0.17B | -0.92% |
| 2023-06-30 | $18.89B | $-0.48B | -2.53% |
| 2023-03-31 | $18.85B | $-0.33B | -1.73% |
| 2022-06-30 | $19.63B | $0.66B | 3.36% |
| 2021-06-30 | $20.30B | $0.68B | 3.37% |
| 2020-06-30 | $19.93B | $0.78B | 3.90% |
| 2019-06-30 | $22.93B | $1.23B | 5.36% |
| 2018-06-30 | $24.26B | $1.37B | 5.64% |
| 2017-06-30 | $25.77B | $1.84B | 7.15% |
| 2016-12-31 | $27.13B | $1.60B | 5.91% |
| 2016-09-30 | $27.08B | $0.87B | 3.22% |
| 2016-06-30 | $26.99B | $0.81B | 3.02% |
| 2016-03-31 | $26.98B | $0.64B | 2.37% |
| 2015-12-31 | $26.92B | $0.72B | 2.66% |
| 2015-09-30 | $26.06B | $0.94B | 3.60% |
| 2015-06-30 | $26.93B | $0.44B | 1.65% |
| 2015-03-31 | $27.58B | $0.48B | 1.72% |
| 2014-12-31 | $28.44B | $0.55B | 1.94% |
| 2014-09-30 | $30.72B | $0.94B | 3.05% |
| 2014-06-30 | $30.80B | $1.45B | 4.70% |
| 2014-03-31 | $30.92B | $1.53B | 4.95% |
| 2013-12-31 | $30.99B | $1.55B | 5.01% |
| 2013-09-30 | $31.41B | $0.52B | 1.65% |
| 2013-06-30 | $31.96B | $0.37B | 1.15% |
| 2013-03-31 | $31.77B | $0.16B | 0.49% |
| 2012-12-31 | $32.19B | $0.27B | 0.84% |
| 2012-09-30 | $31.35B | $0.54B | 1.72% |
| 2012-06-30 | $30.80B | $0.42B | 1.36% |
| 2012-03-31 | $31.11B | $-1.72B | -5.52% |
| 2011-12-31 | $31.33B | $-1.85B | -5.89% |
| 2011-09-30 | $32.59B | $-1.00B | -3.08% |
| 2011-06-30 | $33.09B | $-0.43B | -1.30% |
| 2011-03-31 | $33.49B | $1.84B | 5.48% |
| 2010-12-31 | $33.77B | $1.91B | 5.67% |
| 2010-09-30 | $34.44B | $1.67B | 4.84% |
| 2010-06-30 | $34.60B | $1.25B | 3.60% |
| 2010-03-31 | $34.14B | $0.98B | 2.87% |
| 2009-12-31 | $32.91B | $0.63B | 1.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $23.611B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.329B | 28.06 |
| Boston Scientific (BSX) | United States | $153.315B | 38.38 |
| Stryker (SYK) | United States | $149.550B | 31.27 |
| EssilorLuxottica (ESLOY) | France | $129.320B | 0.00 |
| Medtronic (MDT) | Ireland | $113.223B | 16.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.111B | 26.31 |
| ResMed (RMD) | United States | $37.519B | 28.18 |
| GE HealthCare Technologies (GEHC) | United States | $34.854B | 16.55 |
| Agilent Technologies (A) | United States | $34.275B | 22.34 |
| Terumo (TRUMY) | Japan | $25.791B | 33.50 |
| Insulet (PODD) | United States | $21.226B | 83.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.499B | 11.88 |
| Baxter (BAX) | United States | $15.975B | 11.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.209B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.821B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $3.962B | 17.70 |
| Perrigo (PRGO) | Ireland | $3.748B | 9.50 |
| Haemonetics (HAE) | United States | $3.663B | 16.68 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.419B | 28.41 |
| ICU Medical (ICUI) | United States | $3.352B | 24.72 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.894B | 42.35 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 12.84 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Neogen (NEOG) | United States | $1.135B | 14.53 |
| Phibro Animal Health (PAHC) | United States | $1.133B | 14.48 |
| BioLife Solutions (BLFS) | United States | $1.081B | 0.00 |
| InMode (INMD) | Israel | $0.961B | 9.69 |
| Kestra Medical Technologies (KMTS) | United States | $0.783B | 0.00 |
| Owens & Minor (OMI) | United States | $0.718B | 5.96 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| CeriBell (CBLL) | United States | $0.673B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.458B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 23.60 |
| ZimVie (ZIMV) | United States | $0.279B | 12.67 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.266B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 74.50 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 64.00 |
| Biote (BTMD) | United States | $0.229B | 6.45 |
| OraSure Technologies (OSUR) | United States | $0.229B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.73 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 56.86 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.81 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |